First-Line Treatment of Chronic Lymphocytic Leukemia in Italy: Real-World Evidence on Utilization, Outcomes, and Healthcare Costs

Valentina Perrone,1 Vanessa Innao,2 Stefania Mazzoni,1 Maria Cappuccilli,1 Margherita Andretta,3 Fausto Bartolini,4 Alessandro Chinellato,5 Stefania Dell’Orco,6 Fulvio Ferrante,7 Renato Lombardi,8 Romina Pagliaro,9 Loredana Ubertazzo,10 Paola Valpondi,11 Luca Degli Esposti1 1CliCon S.r.l. Società Be...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Perrone V, Innao V, Mazzoni S, Cappuccilli M, Andretta M, Bartolini F, Chinellato A, Dell'Orco S, Ferrante F, Lombardi R, Pagliaro R, Ubertazzo L, Valpondi P, Degli Esposti L
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Dove Medical Press 2026-06-01
Rangatū:	ClinicoEconomics and Outcomes Research
Ngā marau:	Chronic lymphocytic leukemia First-line treatment Healthcare costs Ibrutinib Real-world evidence Targeted therapy
Urunga tuihono:	https://www.dovepress.com/first-line-treatment-of-chronic-lymphocytic-leukemia-in-italy-real-wor-peer-reviewed-fulltext-article-CEOR
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!